Insulin Pump Management Consensus Statement Released by AACE

Wednesday, October 13, 2010 1:50 pm EDT

Dateline:

JACKSONVILLE, Fla.
"With the proliferation of insulin pump management in medical practices, some guidance is necessary for prospective and current prescribers to assure their optimal and safe use"

JACKSONVILLE, Fla.--(BUSINESS WIRE)--The American Association of Clinical Endocrinologists (AACE) today published a consensus statement for insulin pump management online, and the statement will be published in the next issue of the association’s official medical journal Endocrine Practice.

The new statement addresses the current state of continuous subcutaneous insulin delivery available to patients who require intensive insulin management, the importance of identifying the appropriate patient, the importance of identifying a provider who will offer comprehensive insulin pump management, and the importance of training the patient to use this equipment to achieve their specific goals.

Insulin pumps have been in use for more than 30 years. According to the U.S. Food and Drug Administration, the number of patients using insulin pumps nearly tripled between 2002 and 2007 to approximately 375,000.

“With the proliferation of insulin pump management in medical practices, some guidance is necessary for prospective and current prescribers to assure their optimal and safe use,” said George Grunberger, MD, FACP, FACE, and chair of AACE Task Force on Insulin Pump Management. “Appropriate patient selection is critical and needs to be followed by a thorough assessment of their knowledge of diabetes management principles.”

In the U.S., there is currently no official requirement for medical supervision of this complex diabetes therapy. In addition, no certifying process exists to guide community physicians, patients and their families, payers, or regulators to qualified clinical settings for the initiation of insulin pump therapy.

As a result, any U.S. clinician can prescribe insulin pump therapy. Too often, patients have only support from the product manufacturer and their own efforts to initiate and advance this demanding therapy.

To view a copy of the statement for insulin pump management click here.

To order reprints of AACE consensus statements, please complete the online form at the following link: www.aace.com/reprints.

About the American Association of Clinical Endocrinologists (AACE)

AACE is a professional medical organization with more than 6,000 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes, and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace.

Contact:

American Association of Clinical Endocrinologists
Casey Jones, 904-353-7878 ext. 147
cjones@aace.com